List of articles in "Drug" category - Page 29

Macitentan (trade name Opsumit) is an endothelin receptor antagonist (ERA) approved for the treatment of pulmonary arterial hypertension (PAH). The other two ERAs marketed as of 2014 are bosentan and […]

Bitopertin (GLYT-1; RO-4917838; RG1678) is a drug under development intended to be used in combination with antipsychotics for the treatment of persistent negative symptoms or sub-optimally controlled positive symptoms associated […]

ATL-444 is a drug which acts as a potent and reasonably selective antagonist for the adenosine receptors A1 and A2A. It has been used to study the role of the […]

JD5037 is an antiobesity drug candidate which acts as a peripherally-restricted cannabinoid inverse agonist at CB1 receptors. It is very selective for the CB1 subtype with a Ki of 0.35nM […]

RJR-2429 is a drug that acts as an agonist at neural nicotinic acetylcholine receptors binding to both the α3β4 and the α4β2 subtypes. RJR-2429 is stronger than nicotine but weaker […]

PF-592379 is a drug developed by Pfizer which acts as a potent selective and orally active agonist for the dopamine D3 receptor which is under development as a potential medication […]

Tremorine is a drug which is used in scientific research to produce tremor in animals. This is used for the development of drugs for the treatment of Parkinson’s disease as […]

Morphine methylbromide (Morphine methobromide Morphine bromomethylate Morphosan) a derivative of morphine. It is an opiate listed as a Schedule I controlled substance.

Glafenine is a non-steroidal anti-inflammatory drug (NSAID). Use of glafenine is limited due to the risk of anaphylaxis and acute renal failure.

Rimazolium is a non-narcotic analgesic. It is usually formulated as the mesylate salt rimazolium metilsufate.